6914-79-0Relevant articles and documents
BTK Inhibitors and uses thereof
-
Paragraph 1771; 1780-1782, (2020/05/02)
The invention discloses a bruton's tyrosine kinase (BTK) inhibitor and use thereof. Specifically, the invention provides heteroaromatic compounds or stereoisomers, geometrical isomers, tautomers, racemates, nitrogen oxides, hydrates, solvates, metabolites and pharmaceutically acceptable salts or prodrugs thereof, and pharmaceutical compositions containing the heteroaromatic compounds; the invention also discloses use of the heteroaromatic compounds or the pharmaceutical compositions containing the heteroaromatic compounds in preparation of medicines; the medicines can be used for treating autoimmune diseases, inflammatory diseases or proliferative diseases.
Synthesis, crystal structure and biological activity of 1-cyano-N-phenylcyclopropanecarboxamide
Xue, Yong-Lai,Liu, Xing-Hai,Zhang, Yong-Gang
experimental part, p. 1571 - 1574 (2012/09/07)
A cyclopropane derivative, 1-cyano-N-phenylcyclopropanecarboxamide (C 11H10N2O) was synthesized and its structure was studied by X-ray diffraction, FTIR, 1H NMR spectrum and MS. The crystals are monoclinic, space group Pbc
Synthesis, crystal structure and biological activity of 1-Cyano-N-(4-bromophenyl)cyclopropanecarboxamide
Xue, Yong-Lai,Zhang, Yong-Gang,Liu, Xing-Hai
experimental part, p. 3016 - 3018 (2012/08/29)
A cyclopropane derivative, 1-cyano-N-(4-bromophenyl)cyclopropanecarboxamide (C11H9N2OBr) was synthesized and its structure was studied by X-ray diffraction, FTIR, 1H NMR spectrum and MS. The crystal is triclinic, space group P-1 with α = 8.902(4), β = 10.